Neil R. Ackerman

Neil R. Ackerman

Geen lopende functies

Vermogen: 4 M $ op 31-05-2024

81 jaar
Health Technology
Consumer Services
Finance

Profiel

Dr. Ackerman served in a variety of management positions at Cygnus, Inc from 1994-2005.
He initially led the development efforts for a number of transdermal products, two of which were approved.
He then led the R&D, clinical, regulatory and compliance functions for the Glucowatch Biographer, the first commercially available non-invasive glucose monitor.
From 1990-1994 he was Vice President, Research and Development at Glycomed, leading its discovery efforts in cardiovascular and inflammatory diseases.
From 1982-1990, he was Research Director, Cancer and Inflammatory Diseases with DuPont Pharmaceuticals.
Prior to that time, he had research and management positions at Syntex Corporation and Pfizer, Inc. He is currently an advisor to MMV Financial.
Dr. Ackerman received his Ph.D.
degree from the University of Maryland, and completed a post-doctoral fellowship in immunology at Stanford University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
05-05-2023 62 378 ( 0.01% ) 4 M $ 31-05-2024

Eerdere bekende functies van Neil R. Ackerman

BedrijvenFunctieEinde
Hoofd Techniek/Wetenschap/O&O 01-04-2005
Corporate Officer/Principal -
Ervaring van Neil R. Ackerman in detail bekijken

Opleiding van Neil R. Ackerman

University of Maryland Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Neil R. Ackerman in detail bekijken

Connecties

14

Eerstegraads connecties

3

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit2

Health Technology

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Neil R. Ackerman